2,089
Views
21
CrossRef citations to date
0
Altmetric
Prostate cancer

Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer

, , , , , , & show all
Pages 832-838 | Received 03 Sep 2014, Accepted 29 Oct 2014, Published online: 03 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morten Høyer, Ludvig P. Muren & Bengt Glimelius. (2015) The evolution of radiotherapy techniques in the management of prostate cancer. Acta Oncologica 54:6, pages 821-824.
Read now

Articles from other publishers (20)

Sarthak Shah, Abigail Pepin, Matthew Forsthoefel, Jessica Burlile, Brian T Collins, Suy Simeng, Nima Aghdam & Sean Collins. (2023) Testosterone as a Biomarker for Quality of Life (QOL) Following Androgen Deprivation Therapy (ADT) and Stereotactic Body Radiotherapy (SBRT). Cureus.
Crossref
Donald B. Fuller, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Robert Pfeffer, James R. Gray, Anuj Peddada, Trevor J. Royce & Ronald C. Chen. (2022) High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial. Frontiers in Oncology 12.
Crossref
Carlo Greco, Oriol Pares, Nuno Pimentel, Vasco Louro, Beatriz Nunes, Justyna Kociolek, João Marques & Zvi Fuks. (2022) Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer. Radiotherapy and Oncology 169, pages 35-42.
Crossref
Aneesh K. Pirlamarla, Chase C. Hansen, Mengying Deng, Elizabeth Handorf, Jonathan Paly, J. Karen Wong, Mark A. Hallman, David Y.T. Chen, Daniel M. Geynisman, Alexander Kutikov & Eric M. Horwitz. (2022) Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy. Practical Radiation Oncology 12:1, pages 60-67.
Crossref
Narisa Dewi Maulany Darwis, Takahiro Oike, Nobuteru Kubo, Soehartati A Gondhowiardjo & Tatsuya Ohno. (2020) Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis. Cancers 12:8, pages 2180.
Crossref
S. Roy, A. Loblaw, P. Cheung, W. Chu, H.T. Chung, D. Vesprini, A. Ong, A. Chowdhury, D. Panjwani, G. Pang, R. Korol, M. Davidson, A. Ravi, B. McCurdy, J. Helou, L. Zhang, A. Mamedov, A. Deabreu & H.C. Quon. (2019) Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials. Clinical Oncology 31:9, pages 621-629.
Crossref
Filippo Alongi, Rosario Mazzola, Alba Fiorentino, Stefanie Corradini, Dario Aiello, Vanessa Figlia, Fabiana Gregucci, Riccardo Ballario, Stefano Cavalleri & Ruggero Ruggieri. (2018) Phase II study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancerPhase-II-Studie zur Linac-basierten akzelerierten SBRT in fünf konsekutiven Fraktionen bei lokal begrenztem Prostatakarzinom. Strahlentherapie und Onkologie 195:2, pages 113-120.
Crossref
Michael C. Repka, Simeng Suy, Shaan K. Kataria, Thomas P. Kole, Ima Paydar, Brian T. Collins, Jonathan W. Lischalk, Olusola Obayomi-Davies & Sean P. Collins. 2019. Stereotactic Radiosurgery for Prostate Cancer. Stereotactic Radiosurgery for Prostate Cancer 111 127 .
Younghee Park, Hae Jin Park, Won Il Jang, Bae Kwon Jeong, Hun-Jung Kim & Ah Ram Chang. (2018) Long-term results and PSA kinetics after robotic SBRT for prostate cancer: multicenter retrospective study in Korea (Korean radiation oncology group study 15–01). Radiation Oncology 13:1.
Crossref
Kiyonao Nakamura, Itaru Ikeda, Haruo Inokuchi, Kenji Takayama, Takahiro Inoue, Tomomi Kamba, Osamu Ogawa, Masahiro Hiraoka & Takashi Mizowaki. (2018) A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer. Journal of Radiation Research 59:5, pages 656-663.
Crossref
Li Rebekah Feng, Simeng Suy, Sean P. Collins, Jonathan W. Lischalk, Berwin Yuan & Leorey N. Saligan. (2018) Comparison of Late Urinary Symptoms Following SBRT and SBRT with IMRT Supplementation for Prostate Cancer. Current Urology 11:4, pages 218-224.
Crossref
Shaan KatariaMDMD, Harsha Koneru, Shan Guleria, Malika DannerMDMD, Marilyn Ayoob, Thomas Yung, Siyuan Lei, Brian T. CollinsMDMD, Simeng SuyPhDPhD, John H. LynchMDMD, Thomas KoleMDMD & Sean P. CollinsMD/PhDMD/PhD. (2017) Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?. Frontiers in Oncology 7.
Crossref
Hun Jung Kim, Jeong Hoon Phak & Woo Chul Kim. (2017) Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 13:1, pages 21-27.
Crossref
Fadil Akyol, Melis Gultekin, Gozde Yazici, Pervin Hurmuz, Sezin Yuce Sari & Gokhan Ozyigit. 2017. Principles and Practice of Urooncology. Principles and Practice of Urooncology 375 386 .
Seok Ho Lee, Hun Jung Kim & Woo Chul Kim. (2016) Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 12:4, pages 388-395.
Crossref
Makbule Tambas, Fulya Agaoglu, Ayca Iribas, Murat Guveli, Yavuz Dizdar, Murat Okutan, Dilek Sahin, Nuri Tenekeci & Emin Darendeliler. (2016) Conventionally Fractionationed Volumetric Arc Therapy versus Hypofractionated Stereotactic Body Radiotherapy: Quality of Life, Side Effects, and Prostate-Specific Antigen Kinetics in Localized Prostate Cancer. Value in Health Regional Issues 10, pages 91-99.
Crossref
Amar U. Kishan, Pin-Chieh Wang, Shrinivasa K. Upadhyaya, Henrik Hauswald, D. Jeffrey Demanes, Nicholas G. Nickols, Mitchell Kamrava, Ahmad Sadeghi, Patrick A. Kupelian, Michael L. Steinberg, Nicolas D. Prionas, Mark K. Buyyounouski & Christopher R. King. (2016) SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. Practical Radiation Oncology 6:4, pages 268-275.
Crossref
Jeong Hoon Phak, Hun Jung Kim & Woo Chul Kim. (2016) Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer. Prostate International 4:1, pages 25-29.
Crossref
Jeong Hoon Phak, Hun Jung Kim & Woo Chul Kim. (2016) Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy for low- and intermediate-risk prostate cancer. Cancer Treatment Communications 5, pages 46-50.
Crossref
Hun Jung Kim, Jung Hoon Phak & Woo Chul Kim. (2015) Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer. Prostate International 3:4, pages 118-122.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.